丹红联合美托洛尔治疗冠心病室性期前收缩60例

目的：观察注射丹红注射液联合口服美托洛尔治疗冠心病室性期前收缩临床疗效。方法：将60例冠心病合并有室性期前收缩患者随机分为两组，每组30人，对照组单用美托洛尔治疗；治疗组在此治疗的基础上加用丹红注射液。结果：研究组临床症状改善率为90％，优于对照组的83％（P〈0．05），且药物起效时间较对照组短（尸l〈0．05），研究组显著有效性明显高于对照组（p：0．01）。治疗后两组心电图及Holer均明显改善，但研究组较对照组显效率高。结论：丹红注射液联合美托洛尔治疗冠心病室性期前收缩有临床疗效，且无明显不良反应。

Treating 60 cases of ventricular contraction of coronary heart disease patients with Danhong combined with metoprolol

Objective： To observe the clinical effect of Danhong injection combined with metoprolol in treating ventricular contraction of coronary heart disease （CHD）. Methods： 60 cases of CHD and ventricular contraction patients were randomly divided into treatment group and control group, 30 cases in each group. The control group were treated with metoprolol, on the basis of it, the treatment group added Danhong injection. Results： The clinical symptoms improvement rate of the treatment group was 90%, compared with that of the control group is 83%, there is difference between the two groups, （P〈0.05）, The onset time of drug is shorter than that of the control group （P〈0.05） and the significantly clinical effective is higher than that of the control group （P〈0.01）. After the treatment, the ECG and Holer is significantly improved, but the treatment group is markedly higher. Conclusion： Danhong injection combined with metoprolol have a clinical effict on ventricular contraction of coronary heart disease, and no significant adverse reactions, which is worthy of clinical use.